SCHEMBL25925942

SCHEMBL25925942

CN(C)c1c(/N=N/c2ccnn2C)cc(/N=N/c2ccnn2C)c(O)c1/N=N/c1ccnn1C

nearest known ligand 0.30

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.30
ALDH1A1 P00352 1/20 0.30
MAPT P10636 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25925949 0.80 KCNH2 (0.31) KCNH2
SCHEMBL25925704 0.76 MAPT (0.33) KCNH2ALDH1A1MAPT
SCHEMBL25925941 0.76 KCNH2 (0.34) KCNH2
SCHEMBL25925961 0.75 CCNT1 (0.36) KCNH2ALDH1A1MAPT
SCHEMBL25925733 0.74 ALDH1A1 (0.36) ALDH1A1MAPT
SCHEMBL25925862 0.74 MAPT (0.34) KCNH2ALDH1A1MAPT
SCHEMBL25925882 0.73 AHR (0.36) KCNH2ALDH1A1MAPT
SCHEMBL25926069 0.73 KCNH2 (0.54) KCNH2ALDH1A1MAPT
SCHEMBL25925873 0.72 RAB9A (0.36) KCNH2ALDH1A1MAPT
SCHEMBL25925932 0.71 ESR1 (0.33) ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230242523-A1 COMPOUND, TAUTOMER OF COMPOUND OR SALT OF COMPOUND OR TAUTOMER, METHOD FOR PRODUCING SAME, COLORING COMPOSITION, DYEING METHOD, AND DYED ARTICLE FUJIFILM CORPORATION (JP) 2023-08-03 US disclosed
US-20230242523-A1 COMPOUND, TAUTOMER OF COMPOUND OR SALT OF COMPOUND OR TAUTOMER, METHOD FOR PRODUCING SAME, COLORING COMPOSITION, DYEING METHOD, AND DYED ARTICLE FUJIFILM CORPORATION (JP) 2023-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230242523-A1 COMPOUND, TAUTOMER OF COMPOUND OR SALT OF COMPOUND OR TAUTOMER, METHOD FOR PRODUCING SAME, COLORING COMPOSITION, DYEING METHOD, AND DYED ARTICLE AR, MAPT, NR5A1 KCNH2 3496/4885ALDH1A1 580/4885MAPT 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.